Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multi-center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Study to Assess the Effect of Four Doses of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms

NCT05407064 is registered in ClinicalTrials.gov with Definium Therapeutics US, Inc. as lead sponsor.

NCT NCT05407064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05407064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multi-center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Study to Assess the Effect of Four Doses of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
Lead sponsor
Definium Therapeutics US, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 24, 2022
Completion date
November 27, 2023
Enrollment
198 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety generalized